Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Most doctors don’t know peptides. We list prescribers and clinics that work with compounded peptides — each one’s peptide services confirmed from their own website, with an NPI-verified badge where we can match the provider to the federal registry.
You’ve done the research. You know which peptides you want. But your primary care doctor has never heard of BPC-157 or CJC-1295. Finding a prescriber who actually understands peptide protocols is the hardest part of the process. We solved that.
1 prescriber offering Orforglipron
Clear filtersEvery listing’s peptide services are confirmed from the provider’s own website — never copied from another directory. Providers we match to the NPI registry also get an NPI-verified badge.
Read real patient reviews from people who have used these prescribers for peptide protocols.
Filter for prescribers who offer telehealth consultations. Get a peptide prescription from anywhere in the US.
List your practice for free. Reach patients who are actively looking for peptide-knowledgeable providers.
Claim your listingDisclosed Labs lists 989 peptide-prescribing providers whose peptide services we confirmed from their own website, including 82 who offer telehealth consultations. Of these, 142 are also matched to the federal NPI registry and carry an NPI-verified badge. The directory is growing continuously.
Yes. Any peptide compounded under 503A requires a valid prescription from a licensed provider, and that would remain true for anything the FDA adds to the 503A Bulk Drug Substances List. 7 peptides — BPC-157, KPV, TB-500, MOTs-C, Emideltide (DSIP), Semax, Epitalon — go before the FDA's advisory Pharmacy Compounding Advisory Committee, which meets July 23–24, 2026; the committee recommends and the FDA issues any final rule later. None of them is on the 503A bulks list today. Separately, GHK-Cu (except injectable routes) is in Category 1 — FDA's “under evaluation” enforcement-discretion policy — not a finding of safety or efficacy, and not the 503A bulks list. Our directory helps you find a prescriber who works with compounded peptides.
Every listing starts with first-party confirmation: we crawl the provider's own website and only list them when that site confirms they work with peptides — we never take a third-party directory's word for it. Where we can also match the provider to the federal National Provider Identifier (NPI) registry, the listing gets an NPI-verified badge confirming licensure and specialty. Patient ratings are sourced independently from Google. We confirm peptide services and (for badged listings) licensure — not individual prescribers' peptide-specific training or protocols. Use the listed specialties and reviews to assess fit.
Yes. 82 prescribers in our directory offer telehealth consultations, so you can get a prescription regardless of your location. See our telehealth guide at https://www.disclosedlabs.com/prescribers/telehealth for more on how the process works.
This platform provides informational tools only, not medical advice. Consult a licensed provider. Disclosed Labs does not provide medical advice.
The directory is completely free for patients. We never charge patients to find a prescriber.
Price Comparison
Compare $/mg across 20 verified vendors
Disclosed Labs